Verastem (VSTM) PT Cut To $10 At HCWainwright After Copiktra Underperformance
Tweet Send to a Friend
H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating and cut his price target to $10 from $13 after Verastem ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
